Carrick Therapeutics
Seedtable Score
56
Startups
2
Funding Rounds
7
Investors
$155m
Money raised
Overview
Carrick Therapeutics, based in Dublin, shows strong potential due to its focus on innovative therapies for difficult-to-treat diseases. As a clinical-stage biopharmaceutical company, Carrick targets consumers in need of breakthrough treatments. Significant investments from high-profile venture capital firms demonstrate confidence in the company's strategic direction. Although the market is competitive with existing treatments and ongoing clinical trials, Carrick's emphasis on novel therapeutic approaches could differentiate it. By addressing patient suffering and slow progress in current treatments, Carrick is well-positioned to impact the healthcare sector meaningfully.
- Website: https://carricktherapeutics.com
- Business model: b2c
- Company size: 51 - 101 employees
- Headquarters: Dublin, Ireland
- Founded: 2015
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (7)
Funding
Funding series
Funding Series Analysis
The company Carrick Therapeutics has raised a total of $155m in funding over 2 rounds.
Key Insights:
- Series C: $60m
- Series A: $95m
Carrick Therapeutics Series A (2016, $95M)
$95m
Carrick Therapeutics Series C (2022, $60M)
$60m